Clinical Trial Update: Treating Nightmares in Posttraumatic Stress Disorder With Clonidine and Doxazosin [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating clonidine and doxazosin for PTSD-related nightmares has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• Clonidine (clonidine)
• Doxazosin (doxazosin)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Posttraumatic Stress Disorder | Phase 2 | Status: SUSPENDED